IBB

Thematic Investing Channel

Biotech ETFs Jump: Keep an Eye on XBI, IBB & SBIO

By Frank HolmanJune 18, 2019

Innovative ETFs Channel

Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal

By Max ChenJune 17, 2019

Featured

8 High Flying Biotech ETFs for 2019

By Ian YoungMay 28, 2019

Innovative ETFs Channel

3 Biotech Sector ETFs Bucked the Risk-Off Trend

By Max ChenMay 6, 2019

Relative Value Channel

12 Biggest Healthcare ETFs Ready for Sector Rebound

By Tom LydonApril 24, 2019

Equity ETF Channel

Tom Lydon on Yahoo Finance Live: SPY, Health Care, EM, and What to Avoid

By Ben HernandezApril 16, 2019

Equity ETF Channel

Tom Lydon on CNBC: Can Health Care Cure Itself?

By Ben HernandezApril 15, 2019

Innovative ETFs Channel

Biogen Tanks, Drags Down Biotechnology Sector ETFs

By Max ChenMarch 21, 2019

Innovative ETFs Channel

Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook

By Max ChenMarch 6, 2019

Equity ETF Channel

Biotech ETFs Could See More Inflows

By Tom LydonFebruary 13, 2019

Core ETF Channel

Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook

By Max ChenJanuary 23, 2019

Core ETF Channel

Traders Suggest Treading Carefully With Biotech ETFs

By Brenton GarenJanuary 15, 2019

Equity ETFs

Biotech ETFs Rip Higher to Start 2019

By Brenton GarenJanuary 14, 2019

Equity ETFs

Biotech ETFs Surge After Eli Lilly Buys Out Loxo Oncology

By Max ChenJanuary 7, 2019

Equity ETFs

Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene

By Max ChenJanuary 3, 2019

Equity ETFs

Pharmaceutical ETFs Could Maintain Their Momentum

By Max ChenSeptember 6, 2018

Equity ETFs

7 Healthcare ETFs Among Best Performing Defensive Picks This Year

By Max ChenAugust 22, 2018

Equity ETFs

Biotech ETFs Rally as Illumina Tops Q2 Expectations

By Max ChenJuly 31, 2018